A Case of Rituximab Use as an Induction and Maintenance of Remission in ANCA-Associated Vasculitis
Antineutrophil cytoplasmic antibody- (ANCA-) associated vasculitis (AAV) is a multisystem autoimmune disease affecting mainly microscopic blood vessels due to circulating autoantibodies against neutrophil cytoplasmic antigens. We report a case of a 57-year-old female patient presenting with hemoptys...
Main Authors: | Neveen Awad, Shahd Hafiz, Abdurahman Albeity, Hani Almoallim |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2016-01-01
|
Series: | Case Reports in Rheumatology |
Online Access: | http://dx.doi.org/10.1155/2016/7275860 |
Similar Items
-
Is rituximab effective for induction of remission in ANCA-associated vasculitis?
by: Carmen Rain, et al.
Published: (2015-08-01) -
Combination Therapy With Rituximab and Cyclophosphamide for Remission Induction in ANCA Vasculitis
by: Frank B. Cortazar, et al.
Published: (2018-03-01) -
Rituximab Induction and Maintenance in ANCA-Associated Vasculitis: State of the Art and Future Perspectives
by: Elena Treppo, et al.
Published: (2021-08-01) -
Severe Primary Raynaud’s Disease Treated with Rituximab
by: Mohammed Shabrawishi, et al.
Published: (2016-01-01) -
Ten-year experience with rituximab for induction and maintenance therapy in patients with ANCA-associated systemic vasculitis
by: T. V. Beketova, et al.
Published: (2020-03-01)